EMIT II OPIATES 300/2000 ASSAY

Enzyme Immunoassay, Opiates

BEHRING DIAGNOSTICS, INC.

The following data is part of a premarket notification filed by Behring Diagnostics, Inc. with the FDA for Emit Ii Opiates 300/2000 Assay.

Pre-market Notification Details

Device IDK971596
510k NumberK971596
Device Name:EMIT II OPIATES 300/2000 ASSAY
ClassificationEnzyme Immunoassay, Opiates
Applicant BEHRING DIAGNOSTICS, INC. 3403 YERBA BUENA RD. P.O. BOX 49013 San Jose,  CA  95161 -9013
ContactDavid Kolesar
CorrespondentDavid Kolesar
BEHRING DIAGNOSTICS, INC. 3403 YERBA BUENA RD. P.O. BOX 49013 San Jose,  CA  95161 -9013
Product CodeDJG  
CFR Regulation Number862.3650 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1997-05-01
Decision Date1997-06-25
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00630414596105 K971596 000
00630414568799 K971596 000
00842768014338 K971596 000
00842768001826 K971596 000
00842768001819 K971596 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.